Búsqueda | Biblioteca Virtual en Salud

1.

High-dose recombinant interleukin-2 alone: a regimen with limited activity in the treatment of advanced renal cell carcinoma.

Abrams, J S; Rayner, A A; Wiernik, P H; Parkinson, D R; Eisenberger, M; Aronson, F R; Gucalp, R; Atkins, M B; Hawkins, M J.

J Natl Cancer Inst ; 82(14): 1202-6, 1990 Jul 18.

Artículo en Inglés | MEDLINE | ID: mdl-2194036

2.

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.

Rosenberg, S A; Yannelli, J R; Yang, J C; Topalian, S L; Schwartzentruber, D J; Weber, J S; Parkinson, D R; Seipp, C A; Einhorn, J H; White, D E.

J Natl Cancer Inst ; 86(15): 1159-66, 1994 Aug 03.

Artículo en Inglés | MEDLINE | ID: mdl-8028037

3.

13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin.

Lippman, S M; Parkinson, D R; Itri, L M; Weber, R S; Schantz, S P; Ota, D M; Schusterman, M A; Krakoff, I H; Gutterman, J U; Hong, W K.

J Natl Cancer Inst ; 84(4): 235-41, 1992 Feb 19.

Artículo en Inglés | MEDLINE | ID: mdl-1734084

4.

Inhibitory effects of elevated temperature on human cytokine production and natural killer activity.

Dinarello, C A; Dempsey, R A; Allegretta, M; LoPreste, G; Dainiak, N; Parkinson, D R; Mier, J W.

Cancer Res ; 46(12 Pt 1): 6236-41, 1986 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-2430693

5.

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

Marincola, F M; Venzon, D; White, D; Rubin, J T; Lotze, M T; Simonis, T B; Balkissoon, J; Rosenberg, S A; Parkinson, D R.

Cancer Res ; 52(23): 6561-6, 1992 Dec 01.

Artículo en Inglés | MEDLINE | ID: mdl-1423301

6.

Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma.

Kim, T Y; von Eschenbach, A C; Filaccio, M D; Hayakawa, K; Parkinson, D R; Balch, C M; Itoh, K.

Cancer Res ; 50(17): 5263-8, 1990 Sep 01.

Artículo en Inglés | MEDLINE | ID: mdl-2143685

7.

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

Yang, S C; Grimm, E A; Parkinson, D R; Carinhas, J; Fry, K D; Mendiguren-Rodriguez, A; Licciardello, J; Owen-Schaub, L B; Hong, W K; Roth, J A.

Cancer Res ; 51(14): 3669-76, 1991 Jul 15.

Artículo en Inglés | MEDLINE | ID: mdl-1648441

8.

Retinoids in cancer therapy.

Smith, M A; Parkinson, D R; Cheson, B D; Friedman, M A.

J Clin Oncol ; 10(5): 839-64, 1992 May.

Artículo en Inglés | MEDLINE | ID: mdl-1569455

9.

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

Fyfe, G; Fisher, R I; Rosenberg, S A; Sznol, M; Parkinson, D R; Louie, A C.

J Clin Oncol ; 13(3): 688-96, 1995 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-7884429

10.

Levamisole: known effects on the immune system, clinical results, and future applications to the treatment of cancer.

Stevenson, H C; Green, I; Hamilton, J M; Calabro, B A; Parkinson, D R.

J Clin Oncol ; 9(11): 2052-66, 1991 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-1941064

11.

Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease.

Atkins, M B; Gould, J A; Allegretta, M; Li, J J; Dempsey, R A; Rudders, R A; Parkinson, D R; Reichlin, S; Mier, J W.

J Clin Oncol ; 4(9): 1380-91, 1986 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-3489080

12.

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Edmonson, J H; Ryan, L M; Blum, R H; Brooks, J S; Shiraki, M; Frytak, S; Parkinson, D R.

J Clin Oncol ; 11(7): 1269-75, 1993 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-8315424

13.

Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.

Weber, J; Yang, J C; Topalian, S L; Parkinson, D R; Schwartzentruber, D S; Ettinghausen, S E; Gunn, H; Mixon, A; Kim, H; Cole, D.

J Clin Oncol ; 11(3): 499-506, 1993 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-7680375

14.

Renal dysfunction associated with the administration of high-dose interleukin-2 in 199 consecutive patients with metastatic melanoma or renal carcinoma.

Guleria, A S; Yang, J C; Topalian, S L; Weber, J S; Parkinson, D R; MacFarlane, M P; White, R L; Steinberg, S M; White, D E; Einhorn, J H.

J Clin Oncol ; 12(12): 2714-22, 1994 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-7989949

15.

Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.

Parkinson, D R; Fisher, R I; Rayner, A A; Paietta, E; Margolin, K A; Weiss, G R; Mier, J W; Sznol, M; Gaynor, E R; Bar, M H.

J Clin Oncol ; 8(10): 1630-6, 1990 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-2213100

16.

Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study.

Parkinson, D R; Abrams, J S; Wiernik, P H; Rayner, A A; Margolin, K A; Van Echo, D A; Sznol, M; Dutcher, J P; Aronson, F R; Doroshow, J H.

J Clin Oncol ; 8(10): 1650-6, 1990 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-2213101

17.

Anticancer drug discovery and development throughout the world.

Schwartsmann, G; Ratain, M J; Cragg, G M; Wong, J E; Saijo, N; Parkinson, D R; Fujiwara, Y; Pazdur, R; Newman, D J; Dagher, R; Di Leone, L.

J Clin Oncol ; 20(18 Suppl): 47S-59S, 2002 Sep 15.

Artículo en Inglés | MEDLINE | ID: mdl-12235225

18.

Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC.

Hayakawa, K; Salmeron, M A; Parkinson, D R; Markowitz, A B; von Eschenbach, A C; Legha, S S; Balch, C M; Ross, M I; Augustus, L B; Itoh, K.

J Immunother (1991) ; 10(5): 313-25, 1991 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-1790139

19.

Interleukin-2 alone and in combination with other cytokines in melanoma: the investigational approach at the University of Texas M.D. Anderson Cancer Center.

Parkinson, D R; Talpaz, M; Lee, K H; Legha, S; Markowitz, A B; Itoh, K; Balch, C M; Murray, J L; Zukiwski, A A; Benjamin, R S.

Cancer Treat Rev ; 16 Suppl A: 39-48, 1989 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-2670214

20.

Interleukin-2 in cancer therapy.

Parkinson, D R.

Semin Oncol ; 15(6 Suppl 6): 10-26, 1988 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-3061014

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar: